Full name
SANTE-AP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
SANTE-AP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. RACŁAWICKA 71 / 4, 53-149 WROCŁAW
TAX ID8943122821
Rate company:
SANTE-AP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID8943122821
KRS0000712572
Share capital5,000.00 zł
address
UL. RACŁAWICKA 71 / 4, 53-149 WROCŁAW
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
8943122821
REGON
369247938
KRS
0000712572
Legal form
limited liability company
Register Address
UL. RACŁAWICKA 71 / 4, 53-149 WROCŁAW
Date of registration in KRS
2018-01-10
Date of commencement of economic activity
2018-01-10
Act signature
WR.VI NS-REJ.KRS/26159/18/780/ADE
Pkd codes
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
58.19.Z - Other publishing activities, excluding software publishing
69.20.Z - Accounting, bookkeeping and tax consultancy
70.22 - Head office activities and management consultancy
73.11.Z - Advertising agency activities
73.20.Z - Market research and public opinion polling
82.30.Z - Activities related to organizing fairs, exhibitions, and congresses
Payer VAT status
Active
Vat list bank account(s)
PL91 1160 2202 0000 0005 6392 9909 
PL53 1160 2202 0000 0005 6392 9914 Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Assets  | 12,9 | 12,9 | 50,9 | 293,6 |
Gross profit (loss) | 0 | 0 | 6,1 | -∞ |
Net profit (loss) | 0 | 0 | 5,6 | -∞ |
Cash | 12,9 | 12,9 | 14,3 | 10,5 |
Net income from sale | 266,7 | |||
Liabilities and provisions for liabilities | 32,4 | 15 915,4 | ||
Short time liabilities | 32,4 | |||
Income tax | ||||
Working assets | 12,9 | 12,9 | 48,7 | 277,2 |
Equity capital | 12,9 | 12,9 | 18,5 | 43,3 |
Operating profit (EBIT) | 6,1 | |||
Basic operational activity income | ||||
% | % | % | p.p. | |
Profitability of capital | 0 | 0 | 30,2 | 30,2 |
Equity capital to total assets | 100 | 100 | 36,4 | -63,6 |
Gross profit margin | 2,3 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 44 |
Financial statements
01-01-2023 - 31-12-2023
Activity report
Download xml01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download xml01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download docShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Katarzyna Poleszak
Toruń
CYTOGEN-POLSKA
ŁÓDŹ
Emprime sp. z o.o.
Sękocin Nowy
Przedsiębiorstwo Trans-Med
Zawiercie
UROMED POLAND
TORUŃ
Bioevolution sp. z o.o. sp.k.
Warszawa
"SOLINEA" sp. z o.o. sp.k.
Ciecierzyn
Gama Sp. z o.o.
Ruda Śląska
"FARMEDICA" sp. z o.o.
Warszawa